Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Invasive Bladder Cancer × Lidocaine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 5 Colorectal Neoplasms 4 Stomach Neoplasms 2 Recurrence 2 Prostatic Neoplasms 2 Neuralgia 2 Prostate Biopsy 1 Peripheral Nervous System Diseases 1 Pain, Postoperative 1 Pain, Intractable 1 Ovarian Cysts 1 Oropharyngeal Neoplasms 1 Nevus, Pigmented 1 Neuroma 1 Nerve Block 1 Neoplasms 1 Melanoma 1 Localised Prostate Cancer 1 Liver Neoplasms 1 Invasive Bladder Cancer 1 Intracranial Aneurysm 1 Head and Neck Neoplasms 1 Chronic Pain 1 Cholelithiasis 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Cancer Pain 1 Bowen's Disease 1 Appendicitis 1 Agnosia 1

Interventions

Sodium Chloride 1 Lidocaine 1 Hyperthermic Intraperitoneal Chemotherapy 1 Cystectomy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02924480 2022-03-09

Lidocaine

CAMC Health System

Phase NA Completed

Invasive Bladder Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡